iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE – Get Free Report)’s stock price rose 0.1% during mid-day trading on Tuesday . The stock traded as high as $31.89 and last traded at $31.87. Approximately 11,638 shares traded hands during trading, an increase of 5% from the average daily volume of 11,090 shares. The stock had previously closed at $31.85.
iShares LifePath Target Date 2045 ETF Trading Up 0.1 %
The company has a fifty day moving average of $31.54 and a 200-day moving average of $31.57.
Institutional Investors Weigh In On iShares LifePath Target Date 2045 ETF
A hedge fund recently raised its stake in iShares LifePath Target Date 2045 ETF stock. Citadel Advisors LLC increased its position in iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE – Free Report) by 25.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,277 shares of the company’s stock after buying an additional 2,302 shares during the period. Citadel Advisors LLC owned 3.52% of iShares LifePath Target Date 2045 ETF worth $348,000 at the end of the most recent reporting period.
About iShares LifePath Target Date 2045 ETF
The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.
Featured Articles
- Five stocks we like better than iShares LifePath Target Date 2045 ETF
- What is a Bond Market Holiday? How to Invest and Trade
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Where to Find Earnings Call Transcripts
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- What Makes a Stock a Good Dividend Stock?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for iShares LifePath Target Date 2045 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2045 ETF and related companies with MarketBeat.com's FREE daily email newsletter.